Emergent Trends in Pharma Manufacturing

European pharma facilities absorb an estimated €2.3 billion in annual losses from unplanned downtime. Data silos continue to drive regulatory submission delays of 6–12 months.

Cybersecurity threats to operational technology environments have increased by 300% as manufacturing systems become more connected. And the draft EU GMP Annex 22 — the first regulatory framework governing artificial intelligence in GMP-critical processes — is expected to be formally adopted in 2026, with enforcement beginning in 2027–2028.

At the same time, the industry is navigating an accelerating shift toward advanced therapies, personalised medicines, and temperature-sensitive products that demand tighter integration between manufacturing execution and supply chain operations. The margin for error is shrinking.

Pharma Smart Manufacturing 2026 is a conference taking place on 13–14 October 2026 in Copenhagen, Denmark, that brings together 100+ pharmaceutical and digital transformation leaders to address the most critical challenges facing regulated production environments today.

The conference is themed "From Roadmaps to Real Impact," and designed for practitioners, who are responsible for delivering GMP-compliant digital outcomes across pharmaceutical and biotechnology manufacturing operations.

The event brings practitioners together around the topics that are defining the next generation of pharmaceutical manufacturing operations:

• AI validation in GMP environments and EU GMP Annex 22 compliance
• MES implementation and electronic batch record (eBMR) deployment in regulated facilities
• IT/OT integration architectures for scalable digital manufacturing
• Digital twins for supply chain resilience, scenario planning and disruption prediction
• ALCOA++ data integrity for AI-enabled quality systems
• OT cybersecurity in connected manufacturing environments
• Predictive maintenance integrated with MES and CMMS systems
• Net zero pharmaceutical manufacturing and circular economy principles in production

The 2-day programme is structured around practitioner-led content across case studies, keynotes, panel discussions, interactive sessions, and hands-on workshops.

WORKSHOP 1: Building Your AI Validation Playbook

A practical, step-by-step framework for validating AI in pharmaceutical manufacturing — covering risk-based validation approaches, AI-specific documentation packages, model lifecycle management, and GMP compliance.

WORKSHOP 2: Data Integrity & ALCOA++ in Digital Manufacturing Systems

Building audit-ready data practices for AI-enabled quality systems. Delegates navigate revised Annex 11 requirements, assess their organisation’s data integrity maturity, and design AI-ready data governance frameworks.

For cold chain and temperature-sensitive manufacturing operations, Pharma Smart Manufacturing Conference addresses challenges that directly affect supply reliability and patient access. Biologics, vaccines, and advanced therapies present some of the most demanding supply chain requirements in the industry. A dedicated session at the conference addresses the digital and physical challenges of scaling these therapies, including digital chain of identity and custody management across patients, sites, and distribution partners.

Source: Fleming